Cargando…

Cost Analysis of an Antimicrobial Stewardship Program (ASP) Protocol for Adherence to the 2014 American Academy of Pediatrics (AAP) Palivizumab Prophylaxis Recommendations in a Freestanding Children’s Hospital

BACKGROUND: In 2014, the AAP updated guidelines for administration of palivizumab in children at high risk of respiratory syncytial virus (RSV) disease. The updated guidelines defined high risk patient populations and recommended that eligible inpatients not receive monthly palivizumab prophylaxis b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hines, Andrea Green, Zwiener, Jennifer, Stec, Robin, Heybrock, Brenda, Hegemann, Lindsay, Simonsen, Kari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631133/ http://dx.doi.org/10.1093/ofid/ofx163.1304

Ejemplares similares

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
por: Capizzi, Antonino, et al.
Publicado: (2017)

Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation
por: Goldstein, Mitchell, et al.
Publicado: (2021)

Impact of Patient Diagnoses and Provider Years of Practice on Antimicrobial Stewardship Program (ASP) Activities at a Non-freestanding Children’s Hospital
por: Klatte, J Michael, et al.
Publicado: (2017)

1648. Impact of a Pediatric Antimicrobial Stewardship Program on Optimizing Antibiotic Usage in a Non-Freestanding Children’s Hospital (PEDS-ASP)
por: Siu, Anita, et al.
Publicado: (2023)

Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines
por: Choi, Yoonyoung, et al.
Publicado: (2021)

Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease
por: Chiu, Shuenn-Nan, et al.
Publicado: (2022)

Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
por: Taylor, Richard S.
Publicado: (2021)

2639. Role of Antimicrobial Stewardship Program (ASP) in Monitoring Community Transmission of Respiratory Syncytial Virus (RSV) to Determine Optimal Timing of Inpatient Palivizumab Administration at a Pediatric Hospital
por: Shapiro, Craig, et al.
Publicado: (2023)

Respiratory infections in children up to two years of age on prophylaxis with palivizumab
por: Monteiro, Ana Isabel M. P., et al.
Publicado: (2014)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
por: Olchanski, Natalia, et al.
Publicado: (2018)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
por: Resch, Bernhard
Publicado: (2014)

Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab
por: Manini, Mariana Bueno, et al.
Publicado: (2021)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

Antimicrobial stewardship programs (ASPs): The devil is in the details
por: Cunha, Cheston B., et al.
Publicado: (2013)

The amino acid permease (AAP) genes CsAAP2A and SlAAP5A/B are required for oomycete susceptibility in cucumber and tomato
por: Berg, Jeroen A., et al.
Publicado: (2021)

Impact of an Antimicrobial Stewardship Program (ASP) on the Optimal Selection of Antibiotic Prophylaxis in Cesarean Delivery in a Hospital Without Restrictions on the Use of Antibiotics: First ASP in Costa Rica
por: Madriz, Jose Pablo Diaz, et al.
Publicado: (2017)

Compliance with The RSV Immunoprophylaxis Dosing Schedule in The Polish Registry for Palivizumab (2008-2014)
por: Borecka, Róża, et al.
Publicado: (2019)

AAPS 2017 Abstract Supplement
Publicado: (2017)

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports
por: Cutrera, Renato, et al.
Publicado: (2019)

Economic results of a palivizumab seasonal prophylaxis using a cohorting software and vial sharing
por: Coletta, Elio, et al.
Publicado: (2010)

Risk Factors for Hospitalization due to Lower Respiratory Tract Infection in Preterm Infants on Palivizumab Prophylaxis
por: Oncel, Mehmet Yekta, et al.
Publicado: (2013)

Don't Have a Doubt, Get the Catheter Out: A Nurse-Driven CAUTI Prevention Protocol
por: Schiessler, Melissa M., et al.
Publicado: (2019)

AAPS and PSRC 2016 Abstract Supplement
Publicado: (2016)

Broad-Spectrum Amino Acid Transporters ClAAP3 and ClAAP6 Expressed in Watermelon Fruits
por: Shi, Tianran, et al.
Publicado: (2019)

Periodontitis Prevalence, Severity, and Risk Factors: A Comparison of the AAP/CDC Case Definition and the EFP/AAP Classification
por: Germen, Meliha, et al.
Publicado: (2021)

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017)

2095. Antimicrobial Stewardship (ASP) in Rural and Critical Access Hospitals (CAHs) Using TeleStewardship® Services
por: Ased, Sumaya J, et al.
Publicado: (2019)

Do Not Have Doubt, Get the Catheter Out: A Nurse-Driven CAUTI Prevention Protocol
por: Schiessler, Melissa M., et al.
Publicado: (2019)

Abstract: PRS AAPS Poster Proofs 2016
Publicado: (2016)

Abstract: PRS AAPS Oral Proofs 2016
Publicado: (2016)

AAPS Workshop Report on ICH M10
por: Booth, Brian, et al.
Publicado: (2019)

Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review
por: Nathwani, Dilip, et al.
Publicado: (2019)

1079. Impact of Antimicrobial Stewardship Program (ASP) on Patients with Neurological Conditions
por: Hoon Andrea Kwa, Lay, et al.
Publicado: (2019)

Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries
por: Paes, Bosco, et al.
Publicado: (2013)

Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia
por: Al Aql, Fahad, et al.
Publicado: (2016)

Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen
por: Claydon, Jennifer, et al.
Publicado: (2017)

Applied Pharmacometrics (AAPS Advances in the Pharmaceutical Sciences Series)
por: Meibohm, Bernd
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ab45brtfn44lu7nt8ctcl7dtak